APA (7th ed.) Citation

Cipriani, A., Banaschewski, T., & Hollis, C. (2018). Unbalanced risk-benefit analysis of ADHD drugs - authors' reply. The lancet. Psychiatry, 5(11), . https://doi.org/10.1016/S2215-0366(18)30396-1

Chicago Style (17th ed.) Citation

Cipriani, Andrea, Tobias Banaschewski, and Chris Hollis. "Unbalanced Risk-benefit Analysis of ADHD Drugs - Authors' Reply." The Lancet. Psychiatry 5, no. 11 (2018). https://doi.org/10.1016/S2215-0366(18)30396-1.

MLA (9th ed.) Citation

Cipriani, Andrea, et al. "Unbalanced Risk-benefit Analysis of ADHD Drugs - Authors' Reply." The Lancet. Psychiatry, vol. 5, no. 11, 2018, https://doi.org/10.1016/S2215-0366(18)30396-1.